Ganpati Medicity Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -84.75%
(FY 2023)
- Ebitda -84.75%
(FY 2023)
- Net Worth -19.06%
(FY 2023)
- Total Assets
About Ganpati Medicity
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Agarwal and Anil Agarwal serve as directors at the Company.
- CIN/LLPIN
U74120UP2012PTC051525
- Company No.
051525
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2012
- Date of AGM
12 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ganpati Medicity?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Agarwal  | Director | 17-Jul-2012 | Current |
| Anil Agarwal | Director | 17-Jul-2012 | Current |
Financial Performance and Corporate Structure Insights of Ganpati Medicity.
Ganpati Medicity Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 84.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ganpati Medicity?
In 2023, Ganpati Medicity had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gpl Buildtech Private LimitedActive 17 years 6 monthsNikhil Agarwal and Anil Agarwal are mutual person
Ganpati Leasing Infrastructure Private LimitedActive 5 years 3 daysNikhil Agarwal and Anil Agarwal are mutual person
Ganpati Infrastructure Development Company LimitedActive 12 years 8 monthsNikhil Agarwal and Anil Agarwal are mutual person
Ganpati Wellness Private LimitedActive 3 years 6 monthsNikhil Agarwal and Anil Agarwal are mutual person
- Ayush Buildwell (I) Private LimitedActive 18 years 3 months
Nikhil Agarwal and Anil Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ganpati Medicity?
Unlock and access historical data on people associated with Ganpati Medicity, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ganpati Medicity, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganpati Medicity's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
